Overview

To Demonstrate the Relative Bioavailability of Hydroxychloroquine Sulfate, 200 mg Tablets

Status:
Completed
Trial end date:
1993-12-01
Target enrollment:
Participant gender:
Summary
To demonstrate the relative bioavailability of hydroxychloroquine sulfate, 200 mg tablets.
Phase:
Phase 1
Details
Lead Sponsor:
Sandoz
Treatments:
Hydroxychloroquine